Skip to content
Riskpilot
← Back to search
Sign in
Get full access
SALFARM DANMARK A/S
A/S
Active
Advertising protection
CVR 67456211
Nordager 19, 6000
Kolding
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1981 · 44 years old
30 employees
www.salfarm.com
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
SALFARM DANMARK A/S
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
PW
Peter Wendorff Olsen
Management
Management
2008
Former (3)
CP
Christian Pihl
Audit
Audit
1981 – 2008
RA
REVISIONPLUS A/S
Audit
Audit
2008 – 2011
MN
Mette Nørgaard
Management
Management
2008 – 2020
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
SD
Simon Damkjær Wille
Board of Directors
Board of Directors
2024
MD
Michael Degn-Mortensen
Chairman
Chairman
2024
Former (11)
SF
Sune Fraes Diernæs
Board of Directors
Board of Directors
2020 – 2021
MA
Mette Aabel Jensen
Board of Directors
Board of Directors
2009 – 2014
RM
Ronnie Møller-Thorsøe
Board of Directors
Board of Directors
2020 – 2024
TB
Torben Bang
Chairman
Chairman
2019 – 2020
KN
Kristian Nørgaard Hansen
Board of Directors
Board of Directors
2014 – 2020
TB
Thomas Bjerregaard Thomsen
Chairman
Chairman
2020 – 2024
HN
Helmer Nørgaard Olsen
Chairman
Chairman
2009 – 2019
HW
Helene Wendorff Olsen
Board of Directors
Board of Directors
2017 – 2020
BO
Bodil Olsen
Board of Directors
Board of Directors
2012 – 2019
HP
Hans Peter Christian Olsen
Board of Directors
Board of Directors
1981 – 2001
KN
Karen Nørgaard Olsen
Board of Directors
Board of Directors
2008 – 2012
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
SALPHARM HOLDING ApS
Company
100%
100%
2019
HNO HOLDING ApS
Company
10–14.99%
10–14.99%
2002
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on SALFARM DANMARK A/S
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network